Latest News from CGI

• Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials

  RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq: CGIX), a le[...] Read More...

• Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

  Transaction to Create a Leader in Precision Oncology RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 [...] Read More...

• Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates

  Conference call at 8:30 a.m. ET, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEW[...] Read More...

• Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018

  Conference call at 8:30 a.m. EDT, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NE[...] Read More...